Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Utrophin is the autosomal homolog of dystrophin, the product of the Duchenne's muscular dystrophy (DMD) locus. Utrophin is of therapeutic interest since its over-expression can compensate dystrophin's absence. Utrophin is enriched at neuromuscular junctions due to heregulin-mediated utrophin-A promoter activation. We demonstrate that heregulin activated MSK1/2 and phosphorylated histone H3 at serine 10 in cultured C2C12 muscle cells, in an ERK-dependent manner. MSK1/2 inhibition suppressed heregulin-mediated utrophin-A activation. MSK1 over-expression potentiated heregulin-mediated utrophin-A activation and chromatin remodeling at the utrophin-A promoter. These results identify MSK1/2 as key effectors modulating utrophin-A expression as well as identify novel targets for DMD therapy.

Original publication

DOI

10.1016/j.febslet.2007.07.021

Type

Journal article

Journal

FEBS Lett

Publication Date

04/09/2007

Volume

581

Pages

4153 - 4158

Keywords

Animals, Cells, Cultured, Chromatin Assembly and Disassembly, Enzyme Activation, Epigenesis, Genetic, Histones, Mice, Models, Genetic, Muscle Cells, Neuregulin-1, Phosphorylation, Promoter Regions, Genetic, Ribosomal Protein S6 Kinases, 90-kDa, Utrophin